FREE Account Opening + No Clearing Fees + Rs 999 API Access

Beta Drugs IPO Details

Issue Open Sep 29, 2017
Issue Close Oct 4, 2017
IPO Price ₹85
Face Value ₹10
IPO Size ₹19.52 Cr
Listing At NSE SME
IPO Lot Size 1600
Open an Instant Account with Zerodha
  1. Beam Therapeutics inks deal with Pfizer worth up to $1.35B

    Mon, 10 Jan 2022 03:27:00 GMT

    It went public in an upsized IPO in early 2020 and ... Its most advanced drug candidate, for sickle-cell disease and beta thalassemia, is expected to enter Phase 1 clinical trials this year.

  2. Alector Files for IPO to Fund Studies of Alzheimerís, Dementia Drugs

    Thu, 06 Jan 2022 16:00:00 GMT

    In its prospectus, Alector challenges longstanding theories that point to problem proteinsóamyloid beta and tau ... the dose of the drug. The company plans use the IPO proceeds to move on ...

  3. The 10 Best European Stocks for 2022 and Beyond

    Thu, 20 Jan 2022 11:47:00 GMT

    Despite this, European stocks enter 2022 as a beloved asset class among Wall Street strategists, who say the region is a hotbed of value-priced opportunity. As of the start of the year, the Stoxx ...

  4. ALERT: Talis Biomedical Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - TLIS

    Mon, 10 Jan 2022 10:47:00 GMT

    Robbins Geller Rudman & Dowd LLP announces that purchasers of Talis Biomedical Corporation common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the ...

  5. 5 questions facing gene therapy in 2022

    Thu, 13 Jan 2022 09:27:00 GMT

    As record levels of money pour into gene therapy research, biotechs are under increased pressure to address issues related to safety, delivery and overlapping pipelines.

  6. Intel: Semiconductor Chips Or Potato Chips, Quality And Value Prevail

    Fri, 14 Jan 2022 12:55:00 GMT

    Thus, for this article, I limit the details on semiconductor manufacturing, market potential, and the pending Mobileye spinoff IPO to the company ... in the space of drugs. The company was founded ...

  7. Sirnaomics starts 2022 with $64M Hong Kong IPO

    Tue, 04 Jan 2022 14:10:00 GMT

    and Suzhou, China-based company plans to use HK$243.3 million, or about 58% of the proceeds for the development and commercialization for the companyís core product, STP-705, a dual transforming ...

  8. Coordinated Offensive on Alzheimerís Disease

    Thu, 13 Jan 2022 08:48:00 GMT

    Alzheimerís Disease (AD) is a feared diagnosis that afflicts many older individuals, particularly women and those with a genetic predisposition for the condition.†AD is so frightening in large part ...

  9. Super-Rich, But Only For A SecondóMeet The Briefest Billionaires Of 2021

    Wed, 22 Dec 2021 16:00:00 GMT

    Bevritís short flight as a billionaire started with the August IPO via SPAC merger of his Santa ... large losses and its struggle to transition into drug development. 23andMeís shares are ...

  10. Bursa Malaysia to be sole ACE Market IPO approving authority from Jan 1, 2022

    Mon, 20 Dec 2021 04:22:00 GMT

    Bursa will become a one-stop centre for all ACE Market IPO approvals under the new regulatory framework, including the registration of abridged prospectuses for the purpose of secondary ...

  11. Faron Appoints Marie-Louise Fjšllskog as CMO

    Thu, 06 Jan 2022 00:55:00 GMT

    Dr. Fjšllskog has over 30 years of experience in clinical oncology, translational research, and drug development ... in Sensei's successful $152 million IPO, which closed in February 2021.

Beta Drugs IPO Alerts

1. Beta Drugs Limited IPO - Close  Wednesday, September 27, 2017 10:39:31 AM

The issue of Beta Drugs Limited opens on Sep 29, 2017 and closes for subscription on Oct 04, 2017. The equity shares of the company to be list at NSE SME. The price band for the issue has been fixed at Rs 85.

2. Beta Drugs Limited IPO - Open  Wednesday, September 27, 2017 10:39:12 AM

Beta Drugs Limited is entering in the capital market with an IPO of 229,600 Equity Shares of Rs 10 aggregating up to Rs 1.95 Cr. The price band for the issue has been fixed at Rs 85.

Beta Drugs Limited is pharmaceutical formulation manufacturing company engaged in developing, manufacturing and marketing of drug products for domestic and international customers.

The issue opens on Sep 29, 2017 and closes for subscription on Oct 4, 2017. The equity shares of the company to be list at NSE SME platform.

Beta Drugs IPO News & Events FAQs

The Beta Drugs IPO is proposed to open on Sep 29, 2017. The IPO application ends on Oct 4, 2017.

Retail investors can apply in the retail or non-institutional investor category from Sep 29, 2017 to Oct 4, 2017. The Beta Drugs IPO can be applied online through Net Bank (ASBA method) or the stock broker (UPI method).

The Beta Drugs IPO will open for subscription on Sep 29, 2017. The public issue will close on Oct 4, 2017.